News

2016 Feb 16

Partnering up to pursue non-invasive prostate cancer detection

Senior Scientific, LLC, has established a research collaboration with Weill Cornell Medicine to investigate the use of molecularly targeted nanoparticles to non-invasively detect and diagnose prostate cancers. Read more

2016 Feb 15

Among keys to curing cancer, academic medical centers loom large

Dean Laurie Glimcher pens a guest piece about the role academic medical centers will have in realizing Vice President Joe Biden's "moonshot to cure cancer" campaign. Read more

2016 Feb 10

Stem cell transplant in myeloma: Necessity or choice?

Stem cell transplant is a tool, not a necessity when it comes to multiple myeloma, argues Tomer Mark, M.D., MSc. Read more

2016 Feb 09

Precision medicine unleashed

Mark Rubin, M.D., discusses the EXaCT-1 exome sequencing test for cancer developed at the Institute of Precision Medicine. Read more

2016 Feb 08

Sequencing reveals molecular underpinnings of aggressive prostate cancer subtype

A team of researchers led by Himisha Beltran, M.D., discovered the genetic, epigenetic and molecular features that underlie neuroendocrine prostate cancer. Read more

2016 Feb 05

Health By Design

Collaborations between Weill Cornell physician-scientists and Cornell University engineers bring benefits to patients. Read more

2016 Feb 04

Alternatives to Aggressive Therapy in Mantle Cell Lymphoma

Peter Martin, M.D., discusses the evolving paradigm of treatment for mantle cell lymphoma. Read more

Gastrointestinal oncologist Allyson Ocean of the Meyer Cancer Center

2016 Feb 04

Precision medicine, genomics to speed cures for disease

Gastrointestinal oncologist Allyson Ocean, M.D., discusses the use of precision medicine to treat pancreatic cancer. Read more

Sylvia Formenti, M.D., of the Meyer Cancer Center is transforming radiation therapy to trigger the immune system to fight cancer

2016 Feb 04

From foe to friend: Transforming tumors into personalized vaccines

Long a pillar of cancer care, radiation is being used in a new way - to trigger a set of immune responses that converts tumors into internal vaccines. Read more

Manish Shah, M.D., gastrointestinal oncology expert at the Meyer Cancer Center of Weill Cornell Medicine

2016 Feb 02

Targeting cancer stem cells in the BRIGHTER trial

Manish Shah, M.D., discusses a trial into the use of a STAT3 inhibitor with chemotherapy to curtail stem cell regeneration and reduce recurrence or metastasis in gastric cancer. Read more

2016 Feb 01

Treatment options for patients with advanced stomach cancer

For patients with locally advanced stomach cancer, we need to do more than surgery alone, says Manish Shah, M.D. Read more

2016 Jan 29

Neoadjuvant bevacizumab may improve resection of stage III lung cancer

Brendon Stiles, M.D., comments on a study about the addition of bevacizumab Avastin) to induction chemotherapy for lung cancer. Read more

2016 Jan 29

Scientists find link between cancer metabolism and cellular architecture

Researchers exploring the PI3K pathway have discovered a previously unidentified link between a cancer cell's form and shape and its metabolic capabilities Read more

2016 Jan 28

Optune versus salvage chemotherapy in glioblastoma

Susan Panullo, M.D., discusses the improvement in quality of life in patients with glioblastoma treated with Optune. Read more

2016 Jan 27

Parents, physicians urged to prevent cancer with HPV vaccine

The Meyer Cancer Center has joined the nation's top cancer centers calling for increased human papillomavirus (HPV) vaccination for the prevention of cancer. Read more

Innovation from Weill Cornell Medicine scientists + the best medical care from NewYork-Presbyterian doctors puts Meyer Cancer Center first in NYC cancer care.

2016 Jan 27

New 3D goggles help doctors search for mutations in cancerous tumors

Researchers in the lab of Olivier Elemento, Ph.D., are using virtual reality to visualize tumor mutations. Read more

2016 Jan 25

Adjuvant oxaliplatin reduces colon cancer recurrence, deaths

Adding oxaliplatin to fluoropyrimidine-based adjuvant chemotherapy significantly reduces the risk of recurrence of colon cancer, according to Manish Shah, M.D. Read more

2016 Jan 25

Imaging experts create “cancer spray” to illuminate tumors for surgeons

Ching-Hsuan Tung, Ph.D., has developed a fluorescent “cancer spray” that can be applied to the ovaries and other organs during surgery to create a luminous outline of cancerous cell clusters. Read more

2016 Jan 25

Link between prostate protein and adrenal tumors provides new hope for rare cancer

New prostate cancer treatments could provide hope for those with a rare form of endocrine cancer, according to findings from a team of Meyer researchers led by Thomas Fahey III, M.D. Read more

2016 Jan 25

From tracer to treatment: Radiopharmaceuticals home in on hard-to-detect cancers

John Babich, Ph.D., has developed a protocol that combines radiopharmaceuticals and PET scans to improve detection and patient management in prostate cancer. Read more

News

Partnering up to pursue non-invasive prostate cancer detection

Among keys to curing cancer, academic medical centers loom large

Stem cell transplant in myeloma: Necessity or choice?

Precision medicine unleashed

Sequencing reveals molecular underpinnings of aggressive prostate cancer subtype

Health By Design

Alternatives to Aggressive Therapy in Mantle Cell Lymphoma

Precision medicine, genomics to speed cures for disease

From foe to friend: Transforming tumors into personalized vaccines

Targeting cancer stem cells in the BRIGHTER trial

Treatment options for patients with advanced stomach cancer

Neoadjuvant bevacizumab may improve resection of stage III lung cancer

Scientists find link between cancer metabolism and cellular architecture

Optune versus salvage chemotherapy in glioblastoma

Parents, physicians urged to prevent cancer with HPV vaccine

New 3D goggles help doctors search for mutations in cancerous tumors

Adjuvant oxaliplatin reduces colon cancer recurrence, deaths

Imaging experts create “cancer spray” to illuminate tumors for surgeons

Link between prostate protein and adrenal tumors provides new hope for rare cancer

From tracer to treatment: Radiopharmaceuticals home in on hard-to-detect cancers

Follow us on X

2022 Annual Report

2021 Annual Report

2018 Annual Report

2017 Annual Report

2016 Annual Report

Newsletters